Update on investigation by Italian authorities into the supply of stolen medicines
NewsCorporate
Update of 11 August 2014
For the latest information on the medicines concerned and the regulatory actions taken in the context of this investigation, please refer to the medicines regulatory authorities in Italy and Germany:
The previously announced investigation by Italian authorities into the supply of stolen medicines (Herceptin, Remicade and Alimta) has identified two additional products (Avastin and Mabthera) that have been distributed illegally from their territory.
A document is available that lists the batches of Alimta (pemetrexed), Avastin (bevacizumab), Herceptin (trastuzumab), Mabthera (rituximab) and Remicade (infliximab) concerned by the ongoing investigation into the theft of vials of these medicines in Italy, as announced by the European Medicines Agency on 16 and 17 April 2014.